REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Aurofarma S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Commercial and Industrial Machinery and Equipment Rental and Leasing
Full name: Laboratorios Aurofarma S.A.S. Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Laboratorios Aurofarma S.A.S. is based in Colombia. The head office is in Mosquera. It operates in the Pharmaceutical Preparation Manufacturing industry. Laboratorios Aurofarma S.A.S. was incorporated on September 26, 1988. It currently has a total number of 17 (2009) employees. The latest financial highlights indicate a net sales revenue increase of 44.6% in 2025. A growth of 48.6% was recorded in its total assets. The net profit margin of Laboratorios Aurofarma S.A.S. increased by 2.89% in 2025.

Headquarters
Av Troncal Panamericana De Occidente 5 6
Mosquera; Cundinamarca;

Contact Details: Purchase the Laboratorios Aurofarma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Aurofarma S.A.S. report to view the information.
Registered Capital:
Purchase the Laboratorios Aurofarma S.A.S. report to view the information.
Financial Auditors:
Purchase the Laboratorios Aurofarma S.A.S. report to view the information.
Incorporation Date:
September 26, 1988
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorios Aurofarma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
44.6%
Total Operating Revenue
44.87%
Operating Profit
158.86%
EBITDA
141.05%
Net Profit/Loss for the Period
179.23%
Total Assets
48.6%
Total Equity
39.08%
Operating Profit Margin
4.74%
Net Profit Margin
2.89%
Return on Equity (ROE)
18.69%
Debt / Equity
13.7%
Quick Ratio
-0.03%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?